Must antidepressants be avoided in patients with neuroendocrine tumors? Results of a systematic review Review


Authors: Isenberg-Grzeda, E.; MacGregor, M.; Matsoukas, K.; Chow, N.; Reidy-Lagunes, D.; Alici, Y.
Review Title: Must antidepressants be avoided in patients with neuroendocrine tumors? Results of a systematic review
Abstract: OBJECTIVE: Symptoms of depression and anxiety are common in neuroendocrine tumor (NET), yet controversy exists over whether serotonin-mediated antidepressants (SAs) are safe in this population. We sought to address this knowledge gap. METHOD: Following PRISMA guidelines, we conducted a systematic review to identify NET patients who were prescribed SA. RESULTS: We identified 15 articles, reporting on 161 unique patients, 72 with carcinoid syndrome (CS) and 89 without. There was substantial agreement between reviewers at the full-text stage (κ = 0.69). Three of the articles, all with low risk of bias, accounted for most of the cases (149/161; 93%). Among the 72 NET patients with CS prior to antidepressant usage, CS was exacerbated in 6 cases (8%), only 3 (4%) of whom chose to discontinue the antidepressant. The remaining 89 patients had no prior CS symptoms, and none developed CS following antidepressant usage. Overall, no instances of carcinoid crisis or death were reported. CONCLUSIONS: We found no evidence for serious adverse outcomes related to SA usage in NET patients. Previous authors have recommended avoiding antidepressants in NET, but our findings do not support those recommendations. Oncologists should nonetheless monitor for symptom exacerbation when prescribing SA to patients with NET.
Keywords: quality of life; psycho-oncology; carcinoid tumor; neuroendocrine tumors; antidepressive agents; serotonin uptake inhibitors; malignant carcinoid syndrome
Journal Title: Palliative and Supportive Care
Volume: 18
Issue: 5
ISSN: 1478-9515
Publisher: Cambridge University Press  
Date Published: 2020-10-01
Start Page: 602
End Page: 608
Language: English
DOI: 10.1017/s147895152000005x
PUBMED: 32036806
PROVIDER: scopus
PMCID: PMC7416528
DOI/URL:
Notes: Article -- Export Date: 4 January 2021 -- Source: Scopus
Altmetric
Citation Impact
MSK Authors
  1. Yesne Alici
    83 Alici
  2. Diane Lauren Reidy
    284 Reidy